Prevalence of medium-high titer antiphospholipid antibodies over follow-up
| Antiphospholipid antibodies medium-high titers | Variation between beginning and end of follow-up in HCQ+ (%) | Variation between beginning and end of follow-up in HCQ− (%) |
|---|---|---|
| Anticardiolipin IgG | −25% | −4% |
| Anticardiolipin IgM | −0% | +11% |
| Anti-β2 Glycoprotein IgG* | −30% | −7% |
| Anti-β2 Glycoprotein IgM | −28% | −6% |
*Statistically significant (p=0.04).